검색어 : 통합검색[Clement Rene]
총 75건 중 75건 출력
, 8/8 페이지
-
71
- Serotonin 1A and Serotonin 4 Receptors : Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants
- Samuels, Benjamin Adam; Mendez-David, Indira; Faye, Charlè ne; David, Sylvain Andrè é ; Pierz, Kerri A.; Gardier, Alain M.; Hen, Renè é é ; David, Denis J.; Research Foundation for Mental Hygiene, New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY, USA; EA3544 “Pharmacologie des troubles anxio-depressifs et Neurogenese”, Facultè é é é é é de Pharmacie, Universitè é é é é é é Paris-Sud, 5 Rue J-B Clement, Tour D1, 2e etage, F-92296 Chatenay-Malabry, France; EA3544 “Pharmacologie des troubles anxio-depressifs et Neurogenese”, Facultè é é é é é de Pharmacie, Universitè é é é é é é Paris-Sud, 5 Rue J-B Clement, Tour D1, 2e etage, F-92296 Chatenay-Malabry, France; EA3544 “Pharmacologie des troubles anxio-depressifs et Neurogenese”, Facultè é é é é é de Pharmacie, Universitè é é é é é é Paris-Sud, 5 Rue J-B Clement, Tour D1, 2e etage, F-92296 Cha; (The neuroscientist, v.22, 2016, pp.26-45)
-
72
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- van den Bent, Martin J.; Brandes, Alba A.; Rampling, Roy; Kouwenhoven, Mathilde C.M.; Kros, Johan M.; Carpentier, Antoine F.; Clement, Paul M.; Frenay, Marc; Campone, Mario; Baurain, Jean-Francois; Armand, Jean-Paul; Taphoorn, Martin J.B.; Tosoni, Alicia; Kletzl, Heidemarie; Klughammer, Barbara; Lacombe, Denis; Gorlia, Thierry; From the Daniel den Hoed Cancer Center, Rotterdam; and Medisch Centrum Haaglanden, the Hague, the Netherlands; Medical Oncology Department, Bellaria-Maggiore Hospital, Bologna, Italy; Beatson Oncology Centre, Glasgow, United Kingdom; Hopital de la Salpê triè re, Paris; Centre Antoine Lacassagne, Nice; Centre Rene Gauducheau, Nantes, St. Herblain; and Institute Gustave Roussy, Villejuif Cedex, France; Medical Oncology, University Hospital Gasthuisberg, Leuven; Cliniques Universitaires St. Luc, Brussels; and...; From the Daniel den Hoed Cancer Center, Rotterdam; and Medisch Centrum Haaglanden, the Hague, the Netherlands; Medical Oncology Department, Bellaria-Maggiore Hospital, Bologna, Italy; Beatson Oncology Centre, Glasgow, United Kingdom; Hopital de la Salpê triè re, Paris; Centre Antoine Lacassagne, Nice; Centre Rene Gauducheau, Nantes, St. Herblain; and Institute Gustave Roussy, Villejuif Cedex, France; Medical Oncology, University Hospital Gasthuisberg, Leuve; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.27, 2009, pp.1268-1274)
-
73
- Systematic biopsy of the first metastatic event in breast cancer: Results from ESOPE-A prospective multicenter trial.
- Comte, Aurelie; Cottu, Paul H.; Belin, Lisa; Callens, Celine; Servois, Vincent; Bidard, Francois-Clement; Brain, Etienne; Salomon, Anne Vincent-; Bachelot, Thomas Denis; Saghatchian, Mahasti; Campone, Mario; Giacchetti, Sylvie; Bonneterre, Jacques; Sigal-Zafrani, Brigitte; Institut Curie, Paris, France; ; Institut Curie, Paris, France; ; Institut Curie, Paris, France; ; Institut Curie, Saint-Cloud, France; ; Institut Curie, Paris, France; ; Institut Curie, Paris, France; ; Centre Rene Huguenin, St Cloud, France; ; Institut Curie, Paris, France; ; Centre Lé on Bé rard, Lyon, France; ; Institut Gustave Roussy, Villejuif, France; ; Cancer Institute of the West (ICO), Centre René Gauducheau, Medical Oncology Department, Saint-Herblain, France; ; Hopital Saint Louis, Breast Disease Center, Paris, France; ; Centre Oscar Lambret, Lille, France; ; Institut Curie, Paris, France; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.550-550)
-
74
- P05.01.B PROGNOSTIC MARKERS OF DNA METHYLATION AND NGS SEQUENCING IN PROGRESSIVE GLIOBLASTOMA FROM THE EORTC-26101 TRIAL
- Kessler, T; Schrimpf, D; Doerner, L; Hai, L; Kaulen, L; Ito, J; van den Bent, M; Taphoorn, M; Brandes, A A; Idbaih, A; Domont, J; Clement, P M; Campone, M; Bendszus, M; von Deimling, A; Sahm, F; Platten, M; Wick, W; Wick, A; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Erasmus MC Cancer Institute , Rotterdam , Netherlands; Leiden University Medical Center , Leiden , Netherlands; Azienda Unità Sanitaria Locale di Bologna , Bologna , Italy; Sorbonne Université , Paris , France; Institut Gustave Roussy , Villejuif , France; KU Leuven , Leuven , Belgium; Centre Rene Gauducheau , Saint-Herblain , France; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , Heidelberg , Germany; Medical Faculty Mannheim , Mannheim , Germany; Heidelberg University Hospital , Heidelberg , Germany; Heidelberg University Hospital , H; (Neuro-oncology, v.25, 2023, pp.ii43-ii43)
-
75
- Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study
- Rosenthal, Mark; Clement, Paul M; Campone, Mario; Gil-Gil, Miguel J; DeGroot, John; Chinot, Olivier; Idbaih, Ahmed; Gan, Hui; Raizer, Jeffrey; Wen, Patrick Yung; Pineda, Estela; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Mason, Warren; Medical Oncology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Oncology, Leuven Cancer Institute, Leuven, Belgium; Institut de Cancé rologie de l’Ouest, Centre René Gauducheau, Saint Herblain, Pays de la Loire, France; Institut Català d'Oncologia, Barcelona, Spain; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Neuro-Oncology, Assistance Publique - Hô pitaux de Marseille Office Central des Bibliothè ques, Marseille, Provence-Alpes-Cô te d'Azur, France; Department of Neuro-Oncology, Sorbonne Université , Paris, Î le-de-France, France; Oncology, Olivia Newton-John Cancer & Wellness Centre, Heidelberg, Victoria, Australia; Department of Neuro-Oncology, Northwestern Medical Faculty Foundation, Chicago, Illinois, USA; Department of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Medical Oncology, University of Bar; (Esmo open, v.5, 2020, pp.e000672-e000672)
QUICK MENU
